(P-1546) Discordant Clinical and Microbiological Responses are Associated with Late Clinical Relapse in Uncomplicated Urinary Tract Infections: Pooled Analysis of EAGLE-2/EAGLE-3 Trial Data

Friday, October 18, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

Amanda Sheets, PhD

Director, Clinical Development
GSK, Collegeville, PA, USA
Collegeville, Pennsylvania, United States

JA

Judith Absalon, MD

GSK
Collegeville, Pennsylvania, United States
Jeremy Dennison, MD PhD

Director of Clinical Research
GSK, Brentford, UK
Brentford, England, United Kingdom
Caroline R. Perry, PhD (she/her/hers)

Sr Clinical Development Director
GSK, Collegeville, PA, USA
Collegeville, Pennsylvania, United States
Nicole E. Scangarella-Oman, MS (she/her/hers)

Scientific Director
GlaxoSmithKline plc.
Collegeville, Pennsylvania, United States
HM

Helen Millns, PhD

GSK, Stevenage, UK
Stevenage, England, United Kingdom
SJ

Salim Janmohamed, MD

GSK, Brentford, UK
Brentford, England, United Kingdom